Search Results - "KUDRYASHOV, V. E"

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization by Mareev, Yu. V., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Smirnov, A. A., Kudryavtseva, M. M., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for…”
Get full text

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 by Kutishenko, N. P., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Smirnov, А. А., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus…”
Get full text

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry by Lukyanov, M. M., Kutishenko, N. P., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Sgibneva, A. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim . To assess long-term outcomes within 12 months after hospital treatment of patients with coronavirus disease 2019 (COVID-19) as part of a prospective…”
Get full text

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) by Martsevich, S. Yu, Lukyanov, M. M., Pulin, M. M., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelnyy, A. V., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Smirnov, A. A., Kudryashov, E. V., Budaeva, I. V., Nikoshnova, E. S., Karpov, O. E., Drapkina, O. M.

“…Aim . Based on the data from the register of patients with COVID-19 and community-acquired pneumonia (CAP), analyze the duration of the prehospital period,…”
Get full text

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry by Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelny, A. V., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Sgibneva, А. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. According to hospital-based registry, to evaluate the age characteristics and prevalence of concomitant cardiovascular and non-сardiovascular diseases in…”
Get full text

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 by Smirnov, A. A., Loukianov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Maltseva, A. A., Belova, E. N., Klyashtorniy, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular diseases (CVD) and long-term outcomes in post-COVID-19 patients…”
Get full text

Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries) by Andreenko, E. Yu, Lukyanov, M. M., Yakushin, S. S., Makoveeva, A. N., Vorobiev, A. N., Pereverzeva, K. G., Kudryashov, E. V., Klyashtorny, V. G., Dindikova, V. A., Smirnov, A. A., Boytsov, S. A., Drapkina, O. M.

“…Aim. To assess the age and sex characteristics, comorbidities and medication therapy in patients with early cardiovascular multimorbidity in out- and…”
Get full text

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice by Loukianov, M. M., Kontsevaya, A. V., Myrzamatova, A. O., Khudyakov, M. B., Okshina, E. Y., Kudryashov, E. V.

“…Aim. To evaluate the structure of multimorbidity, outcomes and the potential effect of dapagliflozin in patients with a combination of cardiovascular disease…”
Get full text

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register) by Andreenko, E. Yu, Lukyanov, M. M., Yakushin, S. S., Vorobyev, A. N., Kudryashov, E. V., Yavelov, I. S., Klyashtorny, V. G., Pereverzeva, K. G., Boytsov, S. A., Drapkina, O. M.

“…Aim. To assess age and gender characteristics and determine comorbidity, medication, and outcomes in young ambulatory patients with cardiovascular diseases…”
Get full text

Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes by Drapkina, O. M., Karpov, O. E., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Akimkin, V. G., Andrenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelny, A. V., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Kudryashov, E. V., Klyashtorny, V. G., Smirnov, A. A., Fomina, V. S.

“…Aim. To characterize patients admitted to hospital with suspected or documented COVID-19 infection and community-acquired pneumonia (CAP) and to assess the…”
Get full text

Hospital register of patients with acute cerebrovascular accident (REGION): characteristics of patient and outcomes of hospital treatment by Martsevich, S. Yu, Kutishenko, N. P., Lukyanov, M. M., Zagrebelny, A. V., Dmitrieva, N. A., Okshina, E. Yu, Akimova, A. V., Voronina, V. P., Lerman, O. V., Gladilkina, M. P., Krasnikova, G. I., Palamarchuk, V. N., Parsadanyan, N. E., Chernyshova, M. I., Belova, E. N., Kudryashov, E. V., Shamalov, N. A., Arutyunov, G. P., Drapkina, O. M., Boytsov, S. A.

“…Aim. To assess the characteristics of patients and short-term outcomes of the disease in patients hospitalized for cerebral stroke (CS) based on the…”
Get full text

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) by Loukianov, M. M., Andreenko, E. Yu, Martsevich, S. Yu, Yakushin, S. S., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Okshina, E. Yu, Yakusevich, V. V., Yakusevich, V. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N., Mikhin, V. P., Maslennikova, Yu. V., Klyashtorny, V. G., Kudryashov, E. V., Tatsii, Ju. E., Boytsov, S. A., Drapkina, O. M.

“…Aim . To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries…”
Get full text

Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry) by Andreenkо, E. Yu, Loukianov, M. M., Yakushin, S. S., Vorobyev, A. N., Pereverzeva, K. G., Dindikova, V. A., Makoveeva, A. N., Kudryashov, E. V., Boytsov, S. A., Drapkina, O. M.

“…Aim. To evaluate the gender characteristics, educational level, cardiovascular diseases (CVD) risk factors and adherence to drug treatment in patients with…”
Get full text

Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries) by Loukianov, M. M., Martsevich, S. Yu, Andrenko, E. Yu, Yakushin, S. S., Vorobiev, A. N., Pereverzeva, K. G., Zagrebelny, A. V., Okshina, Е. Yu, Yakusevich, V. V., Yakusevich, Vl. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. M., Mikhin, V. P., Maslennikova, Yu. V., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Makoveeva, A. N., Tatsii, Ju. E., Boytsov, S. A., Drapkina, O. M.

“…Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant…”
Get full text

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) by Loukianov, M. M., Martsevich, S. Yu, Drapkina, O. M., Yakushin, S. S., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Yakusevich, V. Val, Yakusevich, V. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N, Mikhin, V. P., Maslennikova, Yu. V., Andreenko, E. Y., Klyashtorny, V. G., Kudryashov, E. V., Okshina, E. Yu, Panagopulu, M. A., Boytsov, S. A.

“…Aim.  To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled…”
Get full text

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes by Loukianov, M. M., Martsevich, S. Yu, Mareev, Yu. V., Yakushin, S. S., Andreenko, E. Yu, Vorobiev, A. N., Pereverzeva, K. G., Zagrebelny, A. V., Okshina, E. Yu, Yakusevich, V. V., Yakusevich, Vl. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N., Mikhin, V. P., Maslennikova, Yu. V., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Makoveeva, A. N., Tatsiy, Yu. E., Boytsov, S. A., Drapkina, O. M.

“…Aim . To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial…”
Get full text

ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC by Stepina, E. V., Loukianov, M. M., Bichurina, M. A., Belova, E. N., Kudryashov, E. V., Uzkov, Ju. V., Boytsov, S. A.

“…Aim. To estimate the rate of oral anticoagulants (OAC) prescription, continuity of anticoagulant therapy in hospital and ambulatory stages along with treatment…”
Get full text

COMPARATIVE CHARACTERISTICS OF MULTIMORBIDITY, DRUG TREATMENT AND OUTCOMES IN POSTSTROKE PATIENTS WITH ATRIAL FIBRILLATION AND WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION (REGISTRY REGION DATA) by Okshina, E. Yu, Loukianov, M. M., Martsevich, S. Yu, Yakushin, S. S., Kutishenko, N. P., Yavelov, I. S., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Dmitrieva, N. A., Kudryashov, E. V., Boytsov, S. A., Drapkina, O. M., Moseichuk, K. A.

“…AIM. Within the framework of outpatient and hospital registers of REGION (REGIster of patients who have undergone acute cerebrovascular accident) to carry out…”
Get full text

Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident by Loukianov, M. M., Yakushin, S. S., Martsevich, S. Yu, Vorobyev, A. N., Pereverzeva, K. G., Okshina, E. Yu, Zagrebelnyy, A. V., Klyashtorny, V. G., Kudryashov, E. V., Boytsov, S. A., Drapkina, O. M.

“…Aim. To estimate outcomes and risk of all-cause mortality, cardiovascular (CV) mortality, and non-fatal CV events in patients with a history of acute…”
Get full text

Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) by Okshina, E. Yu, Loukianov, M. M., Martsevich, S. Yu, Yakushin, S. S., Kutishenko, N. P., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Voronina, V. P., Dmitrieva, N. A., Lerman, O. V., Kudryashov, E. V., Boytsov, S. A., Drapkina, O. M.

“…Aim . To assess the demographic and clinical characteristics, drug treatment and outcomes in patients with a history of acute cerebrovascular accident (ACVA)…”
Get full text